N/A
N=1,216
Preventing Drug Abuse Among Sexual Minority Youth
Substance Abuse
Bottom Line
View on ClinicalTrials.gov: NCT03954535 ↗Enrolled (actual)
1,216
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Average Number of Times Youth Drank Alcohol in the Past Month — 0.83; 1.03 number of times
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Free2b (Behavioral); Attention-Placebo (Behavioral)
- Age
- Pediatric · 15+ yrs
- Sex
- All
- Sponsor
- Columbia University
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Average Number of Times Youth Drank Alcohol in the Past Month |
2.49; 2.67 | — |
| PRIMARY Average Number of Times Youth Drank Alcohol in the Past Month |
2.49; 2.67 | — |
| PRIMARY Average Number of Times Youth Drank Alcohol in the Past Month |
2.49; 2.67 | — |
| PRIMARY Average Number of Times Youth Drank Alcohol in the Past Month |
2.49; 2.67 | — |
| PRIMARY Average Number of Times Youth Binge Drank in the Past Month |
0.65; 0.78 | — |
| PRIMARY Average Number of Times Youth Binge Drank in the Past Month |
0.65; 0.78 | — |
| PRIMARY Average Number of Times Youth Binge Drank in the Past Month |
0.65; 0.78 | — |
| PRIMARY Average Number of Times Youth Binge Drank in the Past Month |
0.65; 0.78 | — |
| PRIMARY Average Number of Times Youth Smoked Cigarettes in the Past Month |
0.76; 1.05 | — |
| PRIMARY Average Number of Times Youth Smoked Cigarettes in the Past Month |
0.76; 1.05 | — |
| PRIMARY Average Number of Times Youth Smoked Cigarettes in the Past Month |
0.76; 1.05 | — |
| PRIMARY Average Number of Times Youth Smoked Cigarettes in the Past Month |
0.76; 1.05 | — |
| PRIMARY Average Number of Times Youth Smoked Marijuana in the Past Month |
8.53; 8.54 | — |
| PRIMARY Average Number of Times Youth Smoked Marijuana in the Past Month |
8.53; 8.54 | — |
| PRIMARY Average Number of Times Youth Smoked Marijuana in the Past Month |
8.53; 8.54 | — |
| PRIMARY Average Number of Times Youth Smoked Marijuana in the Past Month |
8.53; 8.54 | — |
| PRIMARY Average Number of Times Youth Vaped Any Substance in the Past Month |
11.99; 11.11 | — |
| PRIMARY Average Number of Times Youth Vaped Any Substance in the Past Month |
11.99; 11.11 | — |
| PRIMARY Average Number of Times Youth Vaped Any Substance in the Past Month |
11.99; 11.11 | — |
| PRIMARY Average Number of Times Youth Vaped Any Substance in the Past Month |
11.99; 11.11 | — |
| PRIMARY Average Number of Times Youth Used Hard Drugs in the Past Month |
0.34; 0.62 | — |
| PRIMARY Average Number of Times Youth Used Hard Drugs in the Past Month |
0.34; 0.62 | — |
| PRIMARY Average Number of Times Youth Used Hard Drugs in the Past Month |
0.34; 0.62 | — |
| PRIMARY Average Number of Times Youth Used Hard Drugs in the Past Month |
0.34; 0.62 | — |
| SECONDARY Mean Scores for Goal Setting |
2.57; 2.49 | — |
| SECONDARY Mean Scores for Goal Setting |
2.57; 2.49 | — |
| SECONDARY Mean Scores for Goal Setting |
2.57; 2.49 | — |
| SECONDARY Mean Scores for Goal Setting |
2.57; 2.49 | — |
| SECONDARY Mean Scores for Problem Solving |
1.99; 2.03 | — |
| SECONDARY Mean Scores for Problem Solving |
1.99; 2.03 | — |
| SECONDARY Mean Scores for Problem Solving |
1.99; 2.03 | — |
| SECONDARY Mean Scores for Problem Solving |
1.99; 2.03 | — |
| SECONDARY Mean Scores for Self-Esteem |
2.37; 2.42 | — |
| SECONDARY Mean Scores for Self-Esteem |
2.37; 2.42 | — |
| SECONDARY Mean Scores for Self-Esteem |
2.37; 2.42 | — |
| SECONDARY Mean Scores for Self-Esteem |
2.37; 2.42 | — |
| SECONDARY Mean Scores for Perceived Stress |
3.03; 3.14 | — |
| SECONDARY Mean Scores for Perceived Stress |
3.03; 3.14 | — |
| SECONDARY Mean Scores for Perceived Stress |
3.03; 3.14 | — |
| SECONDARY Mean Scores for Perceived Stress |
3.03; 3.14 | — |
| SECONDARY Mean Scores for Coping |
2.87; 2.78 | — |
| SECONDARY Mean Scores for Coping |
2.87; 2.78 | — |
| SECONDARY Mean Scores for Coping |
2.87; 2.78 | — |
| SECONDARY Mean Scores for Coping |
2.87; 2.78 | — |
| SECONDARY Mean Scores for Peer Drug Use |
0.74; 0.77 | — |
| SECONDARY Mean Scores for Peer Drug Use |
0.74; 0.77 | — |
| SECONDARY Mean Scores for Peer Drug Use |
0.74; 0.77 | — |
| SECONDARY Mean Scores for Peer Drug Use |
0.74; 0.77 | — |
| SECONDARY Mean Scores for Self-Efficacy |
2.13; 2.19 | — |
| SECONDARY Mean Scores for Self-Efficacy |
2.13; 2.19 | — |
| SECONDARY Mean Scores for Self-Efficacy |
2.13; 2.19 | — |
| SECONDARY Mean Scores for Self-Efficacy |
2.13; 2.19 | — |
| SECONDARY Mean Scores for Drug Refusal Skills |
1.98; 2.05 | — |
| SECONDARY Mean Scores for Drug Refusal Skills |
1.98; 2.05 | — |
| SECONDARY Mean Scores for Drug Refusal Skills |
1.98; 2.05 | — |
| SECONDARY Mean Scores for Drug Refusal Skills |
1.98; 2.05 | — |
| SECONDARY Mean Scores for Assertiveness |
2.97; 2.93 | — |
| SECONDARY Mean Scores for Assertiveness |
2.97; 2.93 | — |
| SECONDARY Mean Scores for Assertiveness |
2.97; 2.93 | — |
| SECONDARY Mean Scores for Assertiveness |
2.97; 2.93 | — |
| SECONDARY Mean Scores for Consequences of Substance Use |
0.15; 0.13 | — |
| SECONDARY Mean Scores for Consequences of Substance Use |
0.15; 0.13 | — |
| SECONDARY Mean Scores for Consequences of Substance Use |
0.15; 0.13 | — |
| SECONDARY Mean Scores for Consequences of Substance Use |
0.15; 0.13 | — |
Summary
The planned randomized clinical trial will longitudinally test a tailored, web-based drug abuse prevention program with a nationwide sample of 15- to 17-year-old sexual minority youth (youth who identify as gay, lesbian, bisexual, or unsure of their sexual orientation).
Eligibility Criteria
Inclusion Criteria
- teenagers between the ages of 15-17 years old
- identify as lesbian, gay, bisexual, or unsure of sexual orientation
- speak and read English
- access to a private desktop, laptop, or tablet with broadband internet access
Exclusion:
- Lives outside the United States of America
Data sourced from ClinicalTrials.gov (NCT03954535). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.